The effects of zero-balance ultrafiltration on postoperative recovery after cardiopulmonary bypass: a meta-analysis of randomized controlled trials

Objective: Considered as a significant ultrafiltration technology during cardiopulmonary bypass (CPB), zero-balance ultrafiltration (Z-BUF) has always received controversial support regarding its effectiveness in reducing inflammatory mediators in plasma. Therefore, we conducted a meta-analysis to evaluate the clinical effect of Z-BUF through screening all relevant published randomized controlled trials (RCTs). Methods: A comprehensive search was conducted to screen all RCTs of Z-BUF. Three trained investigators searched databases, including PubMed, Embase, the Cochrane Library, Google scholar, and Chinese literature databases (CNKI, WanFang, WeiPu). RCTs that compared Z-BUF with non-ultrafiltration were included. We focused on clinical outcomes such as length of stay in ICU, duration of ventilation, hospital stay, total amount of chest tube drainage and mortality. Finally, a total of 7 studies containing appropriate criteria were divided into an adult group and a pediatric group. A random effects model was used to calculate weighted mean difference with 95% confidence intervals. Results: In the adult group, the benefits of Z-BUF in duration of ventilation (WMD=-2.77, 95% CI = [-6.26, 0.72], I2=71%, p=0.12) and the length of ICU stay (WMD=-4.13, 95% CI = [-10.09, 1.84], I2=77%, Z=1.36, p=0.17) were not apparent, with significant heterogeneity existing in the statistical results. The rest of the clinical parameters could not be evaluated due to insufficient data. In the pediatric group, combined analysis showed Z-BUF could reduce the duration of mechanical ventilation (WMD=3.07; 95%CI= [-7.56, -3.46], I2=17%, p=0.27). The advantage of Z-BUF was not observed in other clinical outcomes. Conclusion: The benefits of Z-BUF were not apparent, according to the report. Further studies involving combined ultrafiltration are expected to provide improved ultrafiltration during CPB.

[1]  T. Katogi,et al.  Modified versus conventional ultrafiltration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials comparing clinical outcome parameters. , 2011, The Journal of thoracic and cardiovascular surgery.

[2]  Howard K. Song,et al.  2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. , 2011, The Annals of thoracic surgery.

[3]  Jia-chun Li,et al.  Effect of subzero-balanced ultrafiltration on lung gas exchange capacity after cardiopulmonary bypass in adult patients with heart valve disease. , 2011, The heart surgery forum.

[4]  Tao Zhang,et al.  Effect of subzero-balanced ultrafiltration on postoperative outcome of patients after cardiopulmonary bypass , 2009, Perfusion.

[5]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[6]  C. Long,et al.  Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass. , 2007, Artificial organs.

[7]  K. Williams,et al.  Ultrafiltration reduces blood transfusions following cardiac surgery: A meta-analysis. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  J. Diephuis,et al.  The effect of zero-balanced ultrafiltration during cardiopulmonary bypass on S100b release and cognitive function , 2003, Perfusion.

[9]  R. Tallman,et al.  Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass , 2002, Perfusion.

[10]  H. Meisner,et al.  Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting. , 1999, Journal of cardiothoracic and vascular anesthesia.

[11]  P. Vouhé,et al.  High-volume, Zero-balanced Hemofiltration to Reduce Delayed Inflammatory Response to Cardiopulmonary Bypass in Children , 1996, Anesthesiology.

[12]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[13]  J. Briegel,et al.  Inflammatory reactions and hydrocortisone in the setting of cardiac surgery: an overview. , 2011, Cardiovascular & hematological agents in medicinal chemistry.

[14]  Gao Zhi-xian Effect of Zero-balanced Ultrafiltration on Postoperative Lung Function in Coronary Artery Bypass Grafting Patients , 2011 .

[15]  Howard K. Song,et al.  Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines , 2011 .

[16]  Wang En-qin Zero-balanced ultrafiltration on perioperative cardiopulmonary function in senile patients undergoing coronary artery bypass graft , 2008 .

[17]  Y. Zheng The Effect of Compound Ultrafiltration on Postoperative Pulmonary Function of Patients with Cardiac Valve Replacement , 2008 .

[18]  Ye Wei Effect of Zero-Balanced Ultrafiltration on Postoperative Lung Function in Replaced Cardiac Valve Cases , 2006 .